Literature DB >> 8756829

Intercellular adhesion molecule-1 mediates acid aspiration-induced lung injury.

T Nagase1, E Ohga, E Sudo, H Katayama, Y Uejima, T Matsuse, Y Fukuchi.   

Abstract

Acid-aspiration-induced injury is one of the leading causes of adult respiratory distress syndrome. Intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte-function-associated antigen-1 alpha (LFA-1 alpha), and it has been shown to be required for leukocyte migration into inflamed areas. The purpose of this report was to investigate the role of the ICAM-1/LFA-1 alpha pathway in a rat model of acid-aspiration-induced injury. Animals received 3.0 ml/kg HCI (0.1N; pH, 1.0) intratracheally pretreated with control monoclonal antibodies (mAbs) (HCI group) or anti-ICAM-1 and LFA-1 alpha mAbs (Test group). In the HCI group, increases in lung resistance (RL) (229 +/- 23% baseline), lung wet-to-dry weight ratio (W/D) (11.9 +/- 0.4), protein concentration (TP) (0.447 +/- 0.054 mg/ml), and the number of neutrophils (PMN) (159.0 +/- 19.4 x 10(4)) of bronchoalveolar lavage fluid were observed. In the Test group, HCI-induced injury was significantly reduced (RL, 122 +/- 7% baseline; W/D, 7.2 +/- 0.1; TP, 0.277 +/- 0.016 mg/ml; PMN, 8.8 +/- 0.8 x 10(4)). The administration of mAbs to ICAM-1 and LFA-1 alpha after HCI instillation partially attenuated HCI-induced responses. These observations suggest that the ICAM-1/LFA-1 alpha pathway might be involved in the pathogenesis of adult respiratory distress syndrome caused by acid aspiration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8756829     DOI: 10.1164/ajrccm.154.2.8756829

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  Host factors influencing the preferential localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue.

Authors:  R M Schiffelers; G Storm; I A Bakker-Woudenberg
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

2.  Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation.

Authors:  Alexander Zarbock; Kai Singbartl; Klaus Ley
Journal:  J Clin Invest       Date:  2006-12       Impact factor: 14.808

3.  VEGF regulates the proliferation of acid-exposed alveolar lining epithelial cells.

Authors:  A Ohwada; Y Yoshioka; K Iwabuchi; I Nagaoka; T Dambara; Y Fukuchi
Journal:  Thorax       Date:  2003-04       Impact factor: 9.139

4.  Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice.

Authors:  T Nagase; S Ishii; K Kume; N Uozumi; T Izumi; Y Ouchi; T Shimizu
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

5.  Inhibition of acid-induced lung injury by hyperosmolar sucrose in rats.

Authors:  Zeenat Safdar; Maimiti Yiming; Gabriele Grunig; Jahar Bhattacharya
Journal:  Am J Respir Crit Care Med       Date:  2005-08-18       Impact factor: 21.405

6.  Surfactant lavage with lidocaine improves pulmonary function in piglets after HCl-induced acute lung injury.

Authors:  T K Huang; C F T Uyehara; V Balaraman; C Y Miyasato; D Person; E Egan; D Easa
Journal:  Lung       Date:  2004       Impact factor: 2.584

7.  Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor.

Authors:  S Ishii; T Kuwaki; T Nagase; K Maki; F Tashiro; S Sunaga; W H Cao; K Kume; Y Fukuchi; K Ikuta; J Miyazaki; M Kumada; T Shimizu
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

Review 8.  Pneumonitis and pneumonia after aspiration.

Authors:  Young Gon Son; Jungho Shin; Ho Geol Ryu
Journal:  J Dent Anesth Pain Med       Date:  2017-03-27

9.  Induced Pluripotent Stem Cell-Derived Conditioned Medium Promotes Endogenous Leukemia Inhibitory Factor to Attenuate Endotoxin-Induced Acute Lung Injury.

Authors:  Vincent Yi-Fong Su; Shih-Hwa Chiou; Wei-Chih Chen; Wen-Kuang Yu; Huai-Hsuan Wu; Hao Chen; Kuang-Yao Yang
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.